BRIEF RESEARCH REPORT article
Front. Genet.
Sec. Human and Medical Genomics
This article is part of the Research TopicInsights in Behavioral and Psychiatric GeneticsView all 8 articles
Differential Genome-wide Association Analysis of Schizophrenia and Post-Traumatic Stress Disorder Identifies Opposing Effects at the MAPT/CRHR1 Locus
Provisionally accepted
- St. Jude Children's Research Hospital, Memphis, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Schizophrenia (SCZ) and post-traumatic stress disorder (PTSD) are severe psychiatric conditions with overlapping yet distinct symptomatology and pathophysiology. Methods: We conducted a differential genome-wide association study (GWAS) to directly compare the genetic architectures of SCZ and PTSD using publicly available GWAS summary statistics from the Psychiatric Genomics Consortium (PGC). Results: We identified four independent loci reaching genome-wide significance (P < 5×10⁻⁸) for differential association between SCZ and PTSD in individuals of European ancestry. These loci (rs62062288, rs58120505, rs12536395, and rs11057189) showed genome-wide significant associations with SCZ and nominal associations with PTSD (all Ps < 0.05) but with opposite directions of effect. Among these, only rs62062288 retained genome-wide significance for PTSD in trans-ancestry meta-analysis, whereas the other three loci showed markedly attenuated PTSD associations (all Ps > 0.001). rs62062288 maps to the 17q21.31 MAPT/CRHR1 locus, exhibiting a risk effect for PTSD and a protective effect for SCZ. GTEx analyses revealed that MAPT and CRHR1 are highly expressed across multiple brain tissues and that rs62062288 shows opposite regulatory effects on MAPT and CRHR1 expression in the brain tissue caudate basal ganglia, with the PTSD risk allele associated with increased MAPT expression and decreased CRHR1 expression. Additional brain-region–specific eQTL effects on CRHR1 were observed in frontal cortex BA9, hippocampus, and spinal cord, indicating tissue-dependent regulation. Conclusion: These findings provide evidence for distinct and opposing genetic contributions to SCZ and PTSD. The identification of the MAPT/CRHR1 locus with brain-region–specific and gene-specific regulatory effects highlights divergent neurodevelopmental and stress-related pathways underlying these disorders.
Keywords: Crhr1, Differential effect size, GWAS, MAPT, PTSD, Schizophrenia
Received: 20 Oct 2025; Accepted: 19 Jan 2026.
Copyright: © 2026 Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Zhongshan Cheng
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.